Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) has issued an announcement.
SMS Pharmaceuticals Limited reported a strong financial performance for the quarter ended June 30, 2025, with a 24% year-on-year increase in Profit After Tax (PAT) and a 19% rise in revenue, driven by higher volumes. The company has also initiated backward integration for key APIs and plans to double its R&D investment over the next 18 months to accelerate pipeline development, alongside a ₹250 crore capital expenditure plan, indicating a robust growth strategy.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and complex Intermediates for global customers.
Average Trading Volume: 8,022
Technical Sentiment Signal: Buy
Current Market Cap: 19.85B INR
For detailed information about SMSPHARMA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “…Tied to the Effort From the Administration” Boeing Stock (NYSE:BA) Blasts Up as Boeing Counts on New Top Sales Rep in China: President Trump
- “We Do Not Have Conflicting Interests….” Microsoft Stock (NASDAQ:MSFT) Gains on New Plan to be the Agentic AI Internet’s Backbone
- Battery Business Suddenly Goes South, Tesla Stock (NASDAQ:TSLA) Notches Up